A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, Sara Hurvitz, Daruka Mahadevan, Dusan Kotasek, Oscar B. Goodman, Erik Rasmussen, Vincent Chow, Gloria Juan, Gregory R. Friberg, Erick Gamelin, Florian D. Vogl, Jayesh Desai
Producción científica: Article › revisión exhaustiva
Profundice en los temas de investigación de 'A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors'. En conjunto forman una huella única.